Testing whether a special heart MRI can replace catheter measurements in congenital heart disease
Compares MRI flow measurements with heart catheterization in people with congenital heart disease.
Plain-language title generated from the registry record
Registry title: Feasibility of Non-invasive Hemodynamic Assessment by 5D Flow in Congenital Heart Disease
Key facts
- Where
- Lausanne, SwitzerlandSee the site
Where in Switzerland
- Lausanne University HospitalLausanne, SwitzerlandNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Tobias Rutz
- Trial code
- NCT07742046
- Record updated
- 3 August 2026
- Original description
This study evaluates whether new flow parameters of the cardiac magnetic resonance imaging (MRI) allow evaluation of parameters for which usually invasive rigth-left heart catheterization are necessary. Patients who require a right-left heart catheterization will undergo the same day a heart catheterization in the MRI. Parameters obtained by MRI will be compared to the gold-standard, the right-left heart catheterization.Read full original descriptionShow less
Evaluation of the Feasibility of Non-invasive Hemodynamic Assessment by 5D Flow in Congenital Heart Disease in Comparison to Right-left Heart Catheterization
This study evaluates whether new flow parameters of the cardiac magnetic resonance imaging (MRI) allow evaluation of parameters for which usually invasive rigth-left heart catheterization are necessary. Patients who require a right-left heart catheterization will undergo the same day a heart catheterization in the MRI. Parameters obtained by MRI will be compared to the gold-standard, the right-left heart catheterization.
Inclusion: Referral for work-up of known or suspected pulmonary hypertension (PH), RVOT pathology, or Fontan-type repair with a clinical indication for RL-HC; Ability to provide informed consent or have consent provided by a legal representative (and assent for minors aged 16-18); Male or female participants of all ethnicities and sociodemographic backgrounds.
Exclusion: Participants unable to comply with study procedures due to language barriers, cognitive or psychological limitations, or lack of legal consent; Patients with contraindications to RL-HC or CMR; Patients not having a clinical indication to RL-HC.